Xenografts models of OV2008 CON cells showed sensitivity toward olaparib, wherein tumors were restrained and even eliminated, while the C/EBPβ-overexpressing group was insensitive to olaparib and had heavier tumor burdens (Supplementary Fig. S4i). Here, CEBPB is linked to neoplasm.